MENU
+Compare
SMRI
ETF ticker: NASDAQ
AS OF
Dec 3, 04:25 PM (EDT)
Price
$36.23
Change
+$0.38 (+1.06%)
Net Assets
494.48M

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Mid-Cap Value
SMRI
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SMRI with price predictions
Nov 28, 2025

SMRI in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 20, 2025

SMRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 15 cases where SMRI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 24, 2025. You may want to consider a long position or call options on SMRI as a result. In of 30 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SMRI just turned positive on November 26, 2025. Looking at past instances where SMRI's MACD turned positive, the stock continued to rise in of 22 cases over the following month. The odds of a continued upward trend are .

SMRI moved above its 50-day moving average on November 21, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SMRI advanced for three days, in of 153 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 171 cases where SMRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Exxon Mobil Corp (NYSE:XOM), Chevron Corp (NYSE:CVX), Merck & Co (NYSE:MRK), Applied Materials (NASDAQ:AMAT), Amgen (NASDAQ:AMGN), QUALCOMM (NASDAQ:QCOM), ConocoPhillips (NYSE:COP), McKesson Corp (NYSE:MCK), Newmont Corp (NYSE:NEM), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF ETF is 64.51B. The market cap for tickers in the group ranges from 7.45B to 491.85B. XOM holds the highest valuation in this group at 491.85B. The lowest valued company is MOH at 7.45B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF ETF was 15%. For the same ETF, the average monthly price growth was 25%, and the average quarterly price growth was 86%. AMAT experienced the highest price growth at 9%, while MCK experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF ETF was -69%. For the same stocks of the ETF, the average monthly volume growth was -71% and the average quarterly volume growth was -61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 41
Price Growth Rating: 43
SMR Rating: 51
Profit Risk Rating: 50
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
SMRI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapValue

Profile
Fundamentals
Details
Category
Mid-Cap Value
Address
Alpha Architect ETF Trust213 Foxcroft Road, Broomall, PennsylvaniaBroomall
Phone
N/A
Web
www.valueshares.com